A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab

A Follow-Up Study of a European IgG4-Related Disease Cohort Treated with Rituximab

Objectives: IgG4-related disease (IgG4-RD) is a chronic fibro-inflammatory disorder affecting virtually any organ. Type 1 autoimmune (type 1 AIP) is its pancreatic manifestation. To date, steroids are considered the first-line pancreatitis treatment. The CD20-binding antibody rituximab (RTX) appears...

Full description

Bibliographic Details
Main Authors: Johanna Backhus, Christian Neumann, Lukas Perkhofer, Lucas A Schulte, Benjamin Mayer, Thomas Seufferlein, Martin Müller, Alexander Kleger
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
IgG4-related disease
autoimmune pancreatitis
rituximab
Responder Index
Online Access:https://www.mdpi.com/2077-0383/10/6/1329

Internet

https://www.mdpi.com/2077-0383/10/6/1329

Similar Items